share_log

ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3

ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3

ThinkEquity開啓了BioVie的買入評級,並宣佈目標價爲3美元
Benzinga ·  07/01 06:52

ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.

ThinkEquity分析師Ashok Kumar開始對BioVie (納斯達克股票代碼:BIVI)進行買入評級,並宣佈目標價爲3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論